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We all recognize that today's healthcare megatrends are challenging to people, practitioners, scientists, healthcare systems, governments and life science companies. This is particularly true for the increasingly frequent chronic conditions in which these trends coalesce. 1 How do we handle the complexity of delivering personalized medicine that reflects individual preferences while taking advantage of the evidence base? 2 What is the answer for the rising cost of both the proliferation of treatments effective for chronic conditions 3 and those of conducting clinical research? 4 Finally, how do we address the new business challenge for healthcare providers to move away from paying for volumes of services in favor of paying for the value of health outcomes achieved by the patients they serve who have lifelong chronic health problems? 5 It is critical for systems wishing to help patients and their communities optimize health to learn to partner with patients in all aspects of care re-design, from planning through delivering services and evaluating outcomes. Moreover, the focus of this partnership will be on improving health, including the contribution that healthcare services make. Methods that facilitate the systematic inclusion and amplification of the patient voice, such as patient reported outcome measures, help us change the focus of the conversation. 6 In this paper, we propose an approach that supports a shift towards a culture of health by facilitating new conversationsbases for culture and cultural change-among all stakeholders involved. We will provide an example of a learning health system that promotes specific changes that are catalyzed through sharing information and holding conversations among stakeholders to promote healthier lives for people who are living with chronic disease.
The Swedish Rheumatology Quality Registry
The approach that underlies the Swedish Rheumatology Quality Registry (SRQ) can be described as a registry-enabled learning health system 7 as defined by the Institute of Medicine ( Figure 1 ). 8 It features the use of patient reported information alongside clinical information for improving health outcomes for individuals, quality of care for practices and research on treatments and their associated outcomes (http://srq.nu/en/). As described below, the SRQ can foster a culture of learning about ways to generate optimal health and high value care for patients and populations using shared information to set up crucial conversations among key stakeholders.
The SRQ approach: using data and information to stimulate crucial conversations Viewing the activity inside the dotted oval, the patient and the family are depicted on the left side and the clinician and the care team on the right. When these groups interact, e.g. during an office visit, they are able to form a co-production partnership and to discuss how the patient is doing and to decide on the next steps in the plan of care.
The co-production dashboard works by 'feeding forward' both patient-reported and clinical information so that key matters (e.g. patient outcomes, diagnoses, treatments) are displayed in real time. 9 This enables discussion, joint decision-making and the subsequent tracking of outcomes by both the patient and the clinician. The 'feed forward' information becomes part of a shared information environment linked to patient health records and to Viewing the 'clouds' outside the dotted oval, the SRQ approach produces health information that can be shared and used to stimulate crucial conversations among key stakeholders that hold culture-changing potential.
Patient-clinician conversations for co-production
The dashboards enable conversations on patient preferences and outcomes of evidence-based treatments so that patients and their clinicians can create a treatment plan that the patient is ready to adopt in hopes of individually attaining optimal health. At the next encounter, this is repeated: first by checking on what progress has been made on health/disease status and then having a renewed conversation-based on current outcome measures and trends overtime-thereby increasing the knowledge of the patient and provider about what treatment/s work best for the patient. [10] [11] [12] From this core of shared real time health information, used for patient-centered assessment, care planning and outcomes tracking, all else emerges.
Patient-family conversations
Patients and families can use the dashboards for tracking patient-reported outcomes between visits and to see for themselves if they are getting worse, getting better or staying the same, and can infer from this about how their treatments and self-care actions may be impacting their health outcomes.
(Visit http://healthstories.se/?¼13 to see an example of how a dashboard is used by a patient).
Community of patients conversations
Using patient facilitated network principles, 13 patients can communicate with other patients 'like them' to share practical knowledge, raise questions for research, and help one another cope with their disease to attain better individual health. This feature is planned by the SRQ as well as the Cystic Fibrosis registry in Sweden and the US.
Clinical team conversations
Clinicians and care teams can use the dashboards before seeing patients for pre-visit planning and also use them during the visit as a basis for real time automated reminders to prompt inclusion of patients in randomized controlled trials 14 and biobank sampling. However, many clinicians believe that the most valuable feature of the dashboard is to use the co-produced information to focus limited appointment time on critical issues identified by the patient-reported and clinical information. The individual, real time information can also be used for population management based on three simple rules: (i) patients in remission at a visit are not given a return appointment; (ii) patients experiencing a disease flare can make an immediate return appointment; and (iii) patients having active disease at a visit receive a treatment change and a quick return visit to evaluate improvement. The result is a clinic driven by patient need that can also improve effectiveness because the patients most in need receive the most resources. It is called 'OpenTight' clinic based on the goal of keeping the schedule free of unnecessary routine follow-up visits (Open) so that appointments are available for those who need return visits to improve health (Tight). The goal is to keep all patients in remission; patients who have not requested an appointment within the past year are contacted by a nurse to confirm that they are still in remission. Application of such rules always requires a continued conversation between the patient and her care team. Resulting outcomes of a population cared for in this way could be nationally outstanding. 15 Conversations among other key stakeholders The information on patient characteristics, disease course, interventions and outcomes all flow from the interactions between patients and clinicians. Once checked and verified by a clinician, they can be copied to the registry database, analyzed and shown on a group level for a multitude of purposes and shared with key stakeholders to have further conversations such as those highlighted below.
• Benchmarking and Transparency Conversations: Using case-mix adjusted comparative data on outcomes and treatments, the SRQ provides performance information to healthcare programs, systems and national authorities. 16 These entities can then learn about best practices, guidelines and care models by talking with 'top performers' with the best outcomes and then measure the impact of adopting new methods by tracking their own results. Also, the societal goals of equal care and outcomes across age, gender, socio-economic groups and geographic regions are elucidated in transparent public reports as a basis for conversations on actions needed by healthcare systems and by the government.
• Research Conversations: The SRQ is engaged in many conversations with researchers with the aim of gaining new scientific knowledge to improve future health outcomes for today's patients and for future patients. The SRQ variables are generally based on scientific validation and often international consensus. Researchers introduce new variables based on recent scientific knowledge and novel approved therapies. In return, using the SRQ in real time during clinical visits and automated reminders enable recruitment of patients for research.
• Registry-Industry Conversations: The SRQ has long experience of providing post approval analyses to medical companies regarding new products that are often mandated by national or international authorities. 17 Companies commissioning registry-based queries or analyses only receive answers to their specific questions, never access to the registry data. The ensuing conversations are aimed at finding the best way to use each product to optimize health in patient groups, and may also be stratified for individual types of disease courses or life styles such as smoking.
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Beginning to adopt the SRQ model in the United States: a pilot test to demonstrate proof of concept A team from Dartmouth, Karolinska Institutet and Cincinnati Children's Hospital Medical Center are adapting the SRQ approach 7 to improve the health of people living with cystic fibrosis (CF) in the USA. This project allows us to explore the complexities of applying the Swedish model to a different chronic condition and healthcare context. While we hypothesize that the SRQ approach could be used for most chronic conditions, we believed that testing it out with CF patients was a particularly good fit for several reasons. Both RA and CF are complex diseases and have high variation in outcomes depending on the level of patient/family engagement in daily care. Symptoms and disease burden can best be reported by the individual patient living with the disease. Disease activity often fluctuates overtime, which suggests the importance of tracking disease burden between visits, and encouraging and supporting self-management. People with CF rely on expensive and technologically advanced treatments discovered through years of research-made possible by information captured in the Cystic Fibrosis Foundation (CFF) Patient Registry-which includes clinical and demographic measures on over 90% of the estimated 30 000 people in the USA with CF. 19 Dartmouth and the CFF have engaged six CF centers to codesign and test the SRQ approach. We anticipate that uptake of the model will depend on several factors. First, the availability of achieved results from Sweden serve as a proof of concept, and are coupled with a transformative and generalizable conceptual model. Second, our process relies on the deep engagement of key stakeholders to co-design the adaptation of the SRQ to the United States CF context. Weekly co-design meetings with a diverse group of 20 stakeholders refined the features, functionality and specifications for a coproduction dashboard that would be used by individuals with CF and their healthcare professionals at the point of care. This work was expanded through focus groups and continued co-design with potential end users from six CF programs. The co-design process built support for the model and identified modifications among end users. Third, the model closely aligns with the mission of the CFF, and CFF staff provided monthly review and input into the design. Fourth, CFF and CF clinical program leaders are fully engaged project participants, actively contributing to the codesign and creating the conditions for success: allocating staff time, leading sessions and conveying lessons learned with other leaders in the CF community. Finally, a dedicated team of healthcare delivery scientists and informatics professionals from Dartmouth is available to work with key stakeholders to plan and implement testing, evaluation and dissemination.
Although the pilot test is just getting started, early lessons are emerging: (a) the SRQ model makes intuitive sense and is appealing to patients, families, clinicians and other stakeholders; (b) the idea of co-production of services is attractive but there is skepticism about what proportion and what types of patients, families and clinicians will be able to change longestablished habits; (c) fitting the new data elements and dashboards into the workflows of clinicians and making needed linkages with electronic health records is challenging but doable with sufficient technical expertise and the will to make it happen by clinical teams, patients and families, Our work will determine whether the CF community can adapt the SRQ care model to facilitate more productive conversations between people with CF and their healthcare professionals, and if it generates healthcare strategies that lead to better health outcomes and wellbeing.
Discussion
Meeting the challenges of today's healthcare services through the creation of a culture of health first requires shared ideas of what health is, a shared understanding of whether it has improved and an explicit understanding of how healthcare services contribute to better health.
Clearly, 'health' has a different meaning to each stakeholder and those meanings of health evolve over time. The definitions of health and agreement on next steps to its improvement can reach alignment as the patient and her clinician inform their conversations with shared information. The patient might still experience suffering or be hindered in daily life even if all the 'objective' or evidence-based measures of disease are normal. In the SRQ dashboard, this dichotomy may be displayed as a continuously high patient-reported pain measure despite absence of inflammation indicated by a normal C-reactive protein measure. Conversely, a patient may feel healthy despite the presence of illness ("Health is a state of complete physical, mental, and social well-being and not merely the absence of disease or infirmity." World Health Organization definition of health since 1948). These gaps can form the basis for a constructive conversation on what state of health has been attained currently and over time and what the next best steps to take may be for the individual patient. 10 The practitioner's role moves from fixer to facilitator 20 and the patient's role from following orders to co-deciding on what the next steps should be and then following through on them in day-to-day living. 21 The power gradient changes from empowered practitioner and passive patient to shared power between two experts working side by side to optimize the patient's perceived health. 22 Further challenges are met through conversations about health data on a group level. The aggregated SRQ data on the population of patients, which contains all the individual (privacy-protected) health information from patients and their clinicians, catalyzes the improvement of healthcare services. It allows comparisons of health outcomes at different clinics in real time and can be used for day-to-day governance of healthcare systems.
Continuously updated, aggregated data are particularly useful when effective but expensive treatments are newly approved. 23 The analyses required for post-marketing surveillance-crucial to both life science companies and to national authorities and payers-are performed on the same data from the dashboard used in every day practice, making this effort extremely cost effective. Thus, the biologic drugs for rheumatoid arthritis introduced in 1998 have been allowed to comprise up to 6% of the entire national drug budget in Sweden because the SRQ has provided the evidence for their cost effectiveness and safety. The effort to introduce the SRQ approach into the USA for a different chronic condition is still in its early stages. The principle of gathering health information at the point of care in a nationwide register is the starting point and consensus has been reached on the co-designed dashboard and informatics flow of individual health data. These first steps in introducing the SRQ approach have successfully established a promising beginning for the continued development and pilot testing of the model with various chronic disease populations in different countries and cultural contexts.
Conclusion
The SRQ approach exemplifies a learning system of health where measures of health are negotiated in conversations among a multitude of stakeholders all striving for a culture that seeks optimal health for individuals and populations, at a cost that can be afforded.
This learning system was started by clinicians and researchers and has emerged through complex evolutionary processes that may be described as change from within, 24 as open innovation in healthcare 25 or by combining design theory and systematic evaluation. 26 It has survived for 20 years and prospers as a sort of 'information commons' spreading throughout Sweden and to other chronic conditions. Now we have taken the first steps to bring this approach to the USA in a congenital chronic condition. If the pilot project is successful, other registries might incorporate dashboards that use patient-reported information alongside clinical information to support intelligent co-production of services. We believe that building a registry enabled learning healthcare system may trigger cultural change towards optimal health at the level of patients, practices and nations.
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